| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1570-0232(01)00578-5 |
| P698 | PubMed publication ID | 12015267 |
| P2093 | author name string | Frank T Peters | |
| Hans H Maurer | |||
| Giselher Fritschi | |||
| Dietmar Springer | |||
| P2860 | cites work | Methcathinone: a new and potent amphetamine-like agent | Q28300938 |
| Mass spectrometric investigation of 2-aminopropiophenones and some of their metabolites | Q28325707 | ||
| Screening for detection of new antidepressants, neuroleptics, hypnotics, and their metabolites in urine by GC-MS developed using rat liver microsomes | Q30980956 | ||
| Screening procedures for simultaneous detection of several drug classes used for high throughput toxicological analyses and doping control. A review. | Q34106439 | ||
| Further evidence for an amphetamine-like mechanism of action of the alkaloid cathinone | Q41473516 | ||
| Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry. | Q43996638 | ||
| Gas-chromatographische Charakterisierung organischer Verbindungen. Teil 1: Retentionsindices aliphatischer Halogenide, Alkohole, Aldehyde und Ketone | Q62072901 | ||
| Re-evaluation of the metabolism and excretion of diethylpropion in non-sustained and sustained release formulations | Q69903146 | ||
| The stereoselective metabolism of dimethylpropion and monomethylpropion | Q70012087 | ||
| Screening procedure for detection of antidepressants of the selective serotonin reuptake inhibitor type and their metabolites in urine as part of a modified systematic toxicological analysis procedure using gas chromatography-mass spectrometry | Q74112318 | ||
| P4510 | describes a project that uses | gas chromatography-mass spectrometry | Q873009 |
| P433 | issue | 1 | |
| P304 | page(s) | 25-33 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences | Q2422407 |
| P1476 | title | Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry | |
| P478 | volume | 773 |
| Q39644366 | 'Second-generation' mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function |
| Q36441681 | 4-Methoxy-α-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry |
| Q28249380 | Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones |
| Q28292304 | Analytical Toxicology of Emerging Drugs of Abuse |
| Q35754464 | Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention |
| Q37900939 | Cathinone derivatives: a review of their chemistry, pharmacology and toxicology |
| Q56763257 | Colorimetric detection and chromatographic analyses of designer drugs in biological materials: a comprehensive review |
| Q39761680 | First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry |
| Q34079088 | Identification of ten new designer drugs by GC-MS, UPLC-QTOF-MS, and NMR as part of a police investigation of a Danish internet company |
| Q34504512 | In vitro, in vivo and in silico metabolic profiling of α-pyrrolidinopentiothiophenone, a novel thiophene stimulant |
| Q44777240 | In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step |
| Q96020143 | Intoxication cases associated with the novel designer drug 3',4'-Methylenedioxy-α-pyrrolidinohexanophenone (MDPHP) and studies on its human metabolism by high-resolution mass spectrometry |
| Q38169542 | Khat and synthetic cathinones: a review |
| Q31153032 | Metabolism and toxicological detection of the new designer drug 3',4'-methylenedioxy-alpha-pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometry. |
| Q33188077 | Metabolism and toxicological detection of the new designer drug 4'-methoxy-alpha-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry. |
| Q28212734 | Metabolism of the new designer drug α-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4′-methyl-α-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry |
| Q34994964 | New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme |
| Q45964220 | Studies on the metabolism of mitragynine, the main alkaloid of the herbal drug Kratom, in rat and human urine using liquid chromatography-linear ion trap mass spectrometry. |
| Q37146920 | Successful quantification of 4'-methyl-α-pyrrolidinohexanophenone (MPHP) in human urine using LC-TOF-MS in an autopsy case |
| Q38850097 | Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases |
| Q34377572 | The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.). |
Search more.